SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Strides Arcolab’s Q4 net jumps 30 fold

28 Feb 2012 Evaluate

Strides Arcolab has reported 30 fold rise in consolidated net profit after minority interest at Rs 68.4 crore for the fourth quarter ended December 2011 compared to Rs 2.2 crore reported in the corresponding quarter previous year. The company’s sales for the quarter were up by 50.60% at Rs 686.4 crore compared to the same period a year ago.

The reason for a big jump in profits is mainly on account of a strong performance of injectables and pharmaceuticals business.

The company has recommended dividend at Rs 2.00 per share for the year ended December 31, 2011.

Strides Arcolab is a global pharmaceuticals headquartered in Bangalore, India that develops and manufactures a wide range of IP-led niche pharmaceuticals products with an emphasis on sterlite injectables.

Strides Pharma Scien Share Price

1126.25 4.75 (0.42%)
07-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1903.00
Dr. Reddys Labs. 1353.75
Cipla 1452.35
Zydus Lifesciences 1152.90
Lupin 2489.85
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: